Concepedia

Publication | Open Access

Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced <scp>NSCLC</scp> patients after progression on osimertinib

DOIFull Paper Access

14

Citations

29

References

2021

Year

Yaping Long, Qi Xiong, Qi Song, Yao Li, Xiaoyan Li, Boyu Qin, Ziwei Huang, Yi Hu, Bo Yang
Thoracic Cancer

Abstract

Our study provides the clinical evidence of favoring immunotherapy plus chemotherapy in NSCLC patients after progression on osimertinib.

References

YearCitations

Page 1